Sulforaphane for Alzheimer's Disease

Also known as: Broccoli sprout extract, SFN

Sulforaphane's Nrf2 activation combats oxidative stress — a major driver of neurodegeneration in Alzheimer's.

Mechanism of Action

In Alzheimer's, sulforaphane activates Nrf2 in neurons and astrocytes, upregulating antioxidant defenses (HO-1, NQO1, GST). It reduces amyloid-beta-induced oxidative damage, decreases neuroinflammation through NF-κB suppression, and promotes autophagic clearance of protein aggregates via TFEB activation.

General mechanism: Isothiocyanate from cruciferous vegetables. Nrf2-ARE activator, HDAC inhibitor, NF-κB suppressor, cancer cell apoptosis inducer.

Current Evidence

Preclinical studies show cognitive improvement and reduced amyloid pathology in AD mouse models. Human studies are limited to biomarker endpoints. The Nrf2 pathway is increasingly recognized as a viable therapeutic target.

Clinical Status: Preclinical for Alzheimer's. Phase I/II for other indications. Available as supplement.

Safety Profile

Very safe. Well-tolerated from dietary sources and supplements. Mild GI effects at high doses. Myrosinase co-administration enhances bioavailability.

Key Research Questions

Frequently Asked Questions

How does sulforaphane fight cancer?

Sulforaphane activates Nrf2, the master antioxidant transcription factor, and inhibits HDAC enzymes (epigenetic anti-cancer effect). It induces Phase II detoxification enzymes, reduces NF-κB inflammation, and induces apoptosis in cancer cells while protecting normal cells. Broccoli sprouts contain 20-100x more sulforaphane precursor than mature broccoli.

Sulforaphane supplement vs broccoli sprouts

3-day-old broccoli sprouts contain 20-100x the sulforaphane precursor (glucoraphanin) of mature broccoli. Supplements standardized to glucoraphanin with myrosinase enzyme provide consistent dosing. Clinical trials use 40-60mg sulforaphane equivalent daily.

View glossary entry →

← Back to Alzheimer's Disease Research